Showing results 1 to 20 of 26
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| closedAccess |  | 2018 | Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS | Qian, Xiaozhong; Dimopoulos, Meletios A.; Amateangelo, Michael; Bjorklund, Chad; Towfic, Fadi; Flynt, Erin; Weisel, Katja C.; Ocio, Enrique M. CSIC ORCID ; Peluso, Teresa; Sternas, Lars; Zaki, Mohamed H.; Moreau, Philippe; Thakurta, Anjan | artículo |
| closedAccess |  | Dec-2021 | COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network | Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San Miguel, Jesús F. CSIC ORCID; Avet-Loiseau, Hervé; Mohty, Mohty, Mohamad; Mateos, Maria Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Meletios A.; Gay, Francesca; Einsele, Hermann; Delforge, Michel; Caers, Jo; Weisel, Katja C.; Jackson, Graham; Garderet, Laurent; Donk, Niels W. C. J. van de; Leleu, Xavier; Goldschmidt, Hartmut; Beksac, Meral; Nijhof, Inger; Schreder, Martin; Abildgaard, Niels; Hajek, Roman; Zojer, Niklas; Kastritis, Efstathios; Broijl, Annemiek; Schjesvold, Fredrik; Boccadoro, Mario; Terpos, Evangelos | artículo de revisión |
| openAccess |  | Nov-2021 | Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE | Mateos, Maria Victoria; Dimopoulos, Meletios A.; Cavo, Michele; Suzuki, Kenshi; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Iida, Shinsuke; Bladé, Joan; Ukropec, Jon; Pei, Huiling; Van Rampelbergh, Rian; Kudva, Anupa; Qi, Ming; San-Miguel, Jesús | artículo |
| closedAccess |  | Jun-2021 | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial | Dimopoulos, Meletios A.; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria Victoria; Einsele, Hermann; Orfanidis, Ioannis; Ahmadi, Tahamtan; Ukropec, Jon; Kampfenkel, Tobias; Schecter, Jordan M.; Qiu, Yanping; Amin, Himal; Vermeulen, Jessica; Carson, Robin; Sonneveld, Pieter | artículo |
| openAccess |  | 2020 | Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma | Goldschmidt, Hartmut; Dimopoulos, Meletios A.; Rajkumar, S. Vincent; Weisel, Katja C.; Moreau, Philippe; Chng, Wee-Joo; Mikala, Gábor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Mateos, Maria Victoria | artículo |
| openAccess |  | 2020 | Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Dimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Weisel, Katja C.; San-Miguel, Jesús; Shpilberg, Ofer; Grosicki, Sebastian; Špička, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, R. Z.; Taniwaki, Masafumi; Röllig, Christoph; Einsele, Hermann; Matsumoto, Morio; Wu, Ka Lung; Anderson, Kenneth; Jou, Ying-Ming; Ganetsky, Alex; Singhal, Anil K.; Richardson, Paul G. | artículo |
| openAccess |  | 2014 | Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma | Dimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | Apr-2022 | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial | Terpos, Evangelos; Dimopoulos, Meletios A.; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Pompa, Alessandra; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria Victoria; Einsele, Hermann; Orfanidis, Ioannis; Gries, Katharine S.; Fastenau, John; Liu, Kevin; He, Jianming; Kampfenkel, Tobias; Qiu, Yanping; Amin, Himal; Carson, Robin; Sonneveld, Pieter | artículo |
|  | 21-Jun-2022 | High frequency of central nervous system involvement in transformed Waldenstrom macroglobulinemia | Durot, Eric; Kanagaratnam, Lukshe; Zanwar, Saurabh; Toussaint, Elise; Kastritis, Efstathios; D’Sa, Shirley; Alcoceba, Miguel; Tomowiak, Cécile; Hivert, Bénédicte; Protin, Caroline; Abeykoon, Jithma P.; Vos, Josephine M. I.; Michallet, Anne-Sophie; Rodier, Cyrielle; Dupuis, Jehan; Leprêtre, Stéphane; Merabet, Fatiha; Roussel, Xavier; Zini, Jean-Marc; Regny, Caroline; Patel, Aisha; Morel, Pierre; Roos-Weil, Damien; Treon, Steven P.; Dimopoulos, Meletios A.; García-Sanz, Ramón; Kapoor, Prashant; Castillo, Jorge J.; Delmer, Alain Jacques | carta al director |
| closedAccess |  | 14-Mar-2019 | High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma | Thakurta, Anjan; Ortiz, María; Blecua, Pedro; Towfic, Fadi; Corre, Jill; Serbina, Natalya V.; Flynt, Erin; Yu, Zhinuan; Yang, Zhihong; Palumbo, Antonio; Dimopoulos, Meletios A.; Gutiérrez, Norma Carmen; Goldschmidt, Hartmut; Sonneveld, Pieter; Avet-Loiseau, Hervé | artículo |
| openAccess |  | 2022 | Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström’s Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study | Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A. | artículo |
| openAccess |  | 2020 | International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) | Mateos, Maria Victoria; Kumar, Sumit; Dimopoulos, Meletios A.; González-Calle, Verónica; Kastritis, Efstathios; Hajek, Roman; Fernández de Larrea, Carlos; Morgan, Gareth J.; Merlini, Giampolo; Goldschmidt, Hartmut; Geraldes, Catarina; Gozzetti, Alessandro; Kyriakou, Charalampia; Garderet, Laurent; Hansson, Markus; Zamagni, Elena; Fantl, Dorotea; Leleu, Xavier; Kim, Byung-Su; Esteves, Graça; Ludwig, Heinz; Usmani, Saad Z.; Min, Chang-Ki; Qi, Ming; Ukropec, Jon; Weiss, Brendan M.; Rajkumar, S. Vincent; Durie, B.; San-Miguel, Jesús | artículo |
| openAccess |  | 2020 | Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation: The phase III TOURMALINE-MM4 trial | Dimopoulos, Meletios A.; Špička, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria Victoria; Morgan, Gareth J.; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagar | artículo |
| openAccess |  | 22-May-2020 | Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) | Terpos, Evangelos; Engelhardt, Monika; Cook, Gordon; Gay, Francesca; Mateos, Maria Victoria; Ntanasis-Stathopoulos, Ioannis; Donk, Niels W. C. J. van de; Avet-Loiseau, Hervé; Hajek, Roman; Vangsted, Annette Juul; Ludwig, Heinz; Zweegman, Sonja; Moreau, Philippe; Einsele, Hermann; Boccadoro, Mario; San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Sonneveld, Pieter | artículo |
| closedAccess |  | Feb-2022 | Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study | Schjesvold, Fredrik; Dimopoulos, Meletios A.; Delimpasi, Sosana; Robak, Pawel; Coriu, Daniel; Legiec, Wojciech; Pour, Ludek; Špička, Ivan; Masszi, Tamas; Doronin, Vadim; Minařík, Jiří; Salogub, Galina; Alekseeva, Yulia; Lazzaro, Antonio; Maisnar, Vladimir; Mikala, Gábor; Rosiñol, Laura; Liberati, Anna Marina; Symeonidis, Argiris; Moody, Victoria; Thuresson, Marcus; Byrne, Catriona; Harmenberg, Johan; Bakker, Nicolaas; Hajek, Roman; Mateos, Maria Victoria; Richardson, Paul G.; Sonneveld, Pieter; OCEAN (OP-103) Investigators | artículo |
| openAccess |  | 2018 | Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study | Mohty, Mohamad; Terpos, Evangelos; Mateos, Maria Victoria; Cavo, Michele; Lejniece, Sandra; Beksac, Meral; Amine Bekadja, Mohamed; Legiec, Wojciech; Dimopoulos, Meletios A.; Stankovic, Svetlana; Durán, Maria Soledad; Stefano, Valerio De; Corso, Alessandro; Kochkareva, Yulia; Laane, Edward; Berthou, Christian; Salwender, Hans; Masliak, Zvenyslava; Pečeliūnas, Valdas; Willenbacher, Wolfgang; Silva, João; Louw, Vernon; Nemet, Damir; Borbényi, Zita; Abadi, Uri; Schou Pedersen, Robert; Černelč, Peter; Potamianou, Anna; Couturier, Catherine; Feys, Caroline; Thoret-Bauchet, Florence; Boccadoro, Mario | artículo |
| closedAccess |  | 2014 | New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Ocio, Enrique M. CSIC ORCID ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, Sumit; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2012 | Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment | Chanan-Khan, Asher A.; San Miguel, Jesús F. CSIC ORCID; Ludwig, Heinz; Dimopoulos, Meletios A. | artículo |
| closedAccess |  | 2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja C.; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Ki Min, Chang; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth J.; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B.; Gupta, Neeraj; Labotka, Richard; Rajkumar, S. Vincent | artículo |
| openAccess |  | 2013 | Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G. | artículo |
